Impact of rheumatic diseases on oral health and quality of life

Oral Diseases

Volumn 21, Issue 3, 2015, Pages 342-348

  Ahola, K ^a   Saarinen, A ^a   Kuuliala, A ^a   Leirisalo Repo, M ^a,b   Murtomaa, H ^a   Meurman, J H ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

DMARD; Oral health; Oral health impact profile; Rheumatoid arthritis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH DISCOMFORT; ORAL HEALTH IMPACT PROFILE 14; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATIC DISEASE; SCORING SYSTEM; TEMPOROMANDIBULAR JOINT DISORDER; XEROSTOMIA; CASE CONTROL STUDY; FINLAND; HEALTH; HEALTH SURVEY; PREVALENCE; RHEUMATIC DISEASES; TEMPOROMANDIBULAR JOINT DISORDERS;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; ORAL HEALTH; PREVALENCE; QUALITY OF LIFE; RHEUMATIC DISEASES; TEMPOROMANDIBULAR JOINT DISORDERS; XEROSTOMIA;

EID: 84925011927     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12285     Document Type: Article

References (29)

1. Aliko A, Alushi A, Tafaj A, Lela F (2010). Oral mucosa involvement on rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. Int Dent J 60: 358.
2. Almståhl A, Wikström M (2005). Microflora in oral ecosystems in subjects with hyposalivation due to medicines or of unknown origin. Oral Health Prev Dent 3: 67-76.
3. Andonopoulos AP, Drosos AA, Skopouli FN, Acritidis NC, Moutsopoulos HM (1987). Secondary Sjögrens syndrome in rheumatoid arthritis. J Rheumatol 14: 1098-1103.
4. von Bültzingslöwen I, Sollecito TP, Fox PC et al (2007). Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103: 1-15.
5. Dahlstrom L, Carlsson GE (2010). Temporomandibular disorders and oral health-related quality of life. A systematic review. Acta Odontol Scand 68: 80-85.
6. Deeming GM, Collingwood J, Penberton MN (2005). Methotrexate and oral ulceration. Br Dent J 198: 83-85.
7. Enger TB, Palm Ö, Garen T, Jensen JL. Oral distress in primary Sjögren's syndrome: implications for health-related quality of life. Eur J Oral Sci 2011; 119:474-480.
8. Ergun S, Cekici A, Topcuoglu N et al (2010). Oral status and Candida colonization with Sjögren's syndrome. Med Oral Patol Cir Bucal 15: 310-315.
9. Hedenberg-Magnusson B, Ernberg M, Kopp S (1999). Presence of orofacial pain and temporomandibular disorder in fibromyalgia. A study by questionnaire. Swed Dent J 23: 185-192.
10. Helenius LM, Meurman JH, Helenius I et al (2005). Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 63: 284-293.
11. Helenius LM, Tervahartiala P, Helenius I et al (2006). Clinical, radiographic and MRI findings of the temporomandibular joint in patients with different rheumatic diseases. Int J Oral Maxillofac Surg 35: 983-989.
12. Helkimo MI, Bailey JO Jr, Ash MM Jr (1979). Correlations of electromyographic silent period duration and the Helkimo dysfunction index. Acta Odontol Scand 37: 51-56.
13. Jakobsson U, Hallberg IR (2002). Pain and quality of life among older people with rheumatoid arthritis and/or osteoarthritis: a literature review. J Clin Nurs 11: 430-443.
14. Kalanzis A, Marshman Z, Falconer DT, Morgan PR, Odell EW (2005). Oral effects of low-dose methotrexate treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: 52-62.
15. Klestov AC, Webb J, Latt D et al (1981). Treatment of xerostomia: a double-blind trial in 108 patients with sjögren's syndrome. Oral Surg Oral Med Oral Pathol 51: 594-599.
16. Konttinen YT, Tuominen S, Piirainen H et al (1990). Signs and symptoms in masticatory system in ten patients with mixed connective tissue disease. Scand J Rheumatol 19: 363-373.
17. Larsson P (2010). Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life. Swed Dent J Suppl 204: 11-98.
18. Leung KC, Leung WK, McMillan AS (2007). Supra-gingival microbiota in Sjögren's syndrome. Clin Oral Investig 11: 415-423.
19. Locker D (1988). Measuring oral health: a conceptual framework. Community Dent Health 5: 3-18.
20. Rhodus NL (1989). Xerostomia and glossodynia in patients with autoimmune disorders. Ear Nose Throat J 68: 791-794.
21. Salonen L, Helldén L, Carlsson GE (1990). Prevalence of signs and symptoms of dysfunction in the masticatory system: an epidemiologic study in an adult Swedish population. J Craniomandib Disord 4: 241-250.
22. Slade G (1997). Derivation and validation of a short-form oral health impact profile. Community Oral Epidemiol 25: 284-290.
23. Slade GD, Spencer AJ (1994). Development and evaluation of the Oral Health Impact Profile. Community Dent Health 11: 3-11.
24. Stewart C, Berg K, Reeves W (2008). Salivary dysfunction and quality of life in Sjögren Syndrome. J Am Dent Assoc 139: 291-299.
25. Tarkkila L, Linna M, Tiitinen A, Lindqvist C, Meurman JH (2001). Oral symptoms at menopause-the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92: 276-280.
26. Tschoppe P, Wolgin M, Pischon N, Kielbassa AM (2010). Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int 4: 321-333.
27. Von Korff M, Dworkin SF, Le Resche L, Kruger A (1988). An epidemiologic comparison of pain complaints. Pain 32: 173-183.
28. Voog U, Alstergren P, Leibur E, Kallikorm R, Kopp S (2003). Impact of temporomandibular joint pain on activities of daily living in patients with rheumatoid arthritis. Acta Odontol Scand 61: 278-282.
29. Wolfe F, Häuser W (2011). Fibromyalgia diagnosis and diagnostic criteria. Ann Med 43: 495-502.